Who owns Arca Biopharma Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Arca Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Arca Biopharma stock

Who bought or sold Arca Biopharma Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cable Car Capital 4.0M $7.0M 0% Mar 2024
 View chart
Western Standard 1.4M $2.5M 0% Mar 2024
 View chart
BML Capital Management 707k $1.2M 0% Mar 2024
 View chart
Vanguard Group 454k $798k 0% Mar 2024
 View chart
BlackRock 231k $407k 0% Mar 2024
 View chart
Geode Capital Management 142k $253k 0% Mar 2024
 View chart
Citadel Advisors 56k $100k 354% Mar 2024
 View chart
Dimensional Fund Advisors 43k $76k 0% Mar 2024
 View chart
Standard Life Aberdeen 33k $57k 0% Mar 2024
 View chart
Northern Trust 21k $37k 0% Mar 2024
 View chart
Charles Schwab Investment Management 15k $27k 0% Mar 2024
 View chart
Hrt Financial 13k $22k 100% Mar 2024
 View chart
Tower Research Capital 3.1k $5.4k -17% Mar 2024
 View chart
Parallel Advisors 244.00 $429.000800 0% Mar 2024
 View chart
FMR 201.00 $358.001100 100% Mar 2024
 View chart
Bank of America Corporation 176.00 $312.259200 309% Mar 2024
 View chart
Wells Fargo & Company 80.00 $141.000000 1% Mar 2024
 View chart
Royal Bank of Canada 56.00 $0 0% Mar 2024
 View chart
Qube Research & Technologies 50.00 $89.000000 0% Mar 2024
 View chart
Jpmorgan Chase & Co 18.00 $32.000400 12% Mar 2024
 View chart
Simplex Trading 3.00 $0 -97% Mar 2024
 View chart

Who sold out of Arca Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
Newtyn Management Dec 2023 269k $458k
Bridgeway Capital Management Sep 2023 47k $94k
Susquehanna International Sep 2023 29k $58k
Two Sigma Securities Dec 2023 12k $21k
UBS Group Dec 2023 1.1k $1.9k
Advisor Group Holdings Dec 2023 55.00 $92.999500